Development of MRI Radiofrequency Exposure Risk Probability for Patients and Workers Based on Local Temperature Safety Considerations for Improved Standards

• Forschungsstelle: INNOSUISSE
• Projektnummer: 9193.1;7 PFLS-LS
• Projekttitel Englisch: Development of MRI Radiofrequency Exposure Risk Probability for Patients and Workers Based on Local Temperature Safety Considerations for Improved Standards

Kurzbeschreibung (Deutsch)

Development of MRI Radiofrequency Exposure Risk Probability for Patients and Workers Based on Local Temperature Safety Considerations for Improved Standards

Kurzbeschreibung (Englisch)

Development of MRI Radiofrequency Exposure Risk Probability for Patients and Workers Based on Local Temperature Safety Considerations for Improved Standards

Abstract (Deutsch)

The purpose of this project is to reduce MRI scan times and optimize image quality at lower costs and increase the safety of patients (with and without implants) and MRI personnel. The research tasks are 1) to investigate validated hazard threshold models as a function of the MRI equipment, scanning procedures and implants, 2) to develop appropriate instrumentations and testing procedures and 3) to optimize scanning sequences. The project will be performed by an international consortium, including major MR manufacturers (Philips, Siemens, GE), the regulatory agency FDA and seven leading academic partners in this field, including the MR research group at ETH and the IT'IS Foundation. The instrumentation and test systems will be developed and commercialized by ZMT, a Zurich based start-up company. Overall, the project results will have important economies for society at large, including patients and hospitals as a result of better and safer diagnostics and lower costs.

Abstract (Englisch)

The purpose of this project is to reduce MRI scan times and optimize image quality at lower costs and increase the safety of patients (with and without implants) and MRI personnel. The research tasks are 1) to investigate validated hazard threshold models as a function of the MRI equipment, scanning procedures and implants, 2) to develop appropriate instrumentations and testing procedures and 3) to optimize scanning sequences. The project will be performed by an international consortium, including major MR manufacturers (Philips, Siemens, GE), the regulatory agency FDA and seven leading academic partners in this field, including the MR research group at ETH and the IT'IS Foundation. The instrumentation and test systems will be developed and commercialized by ZMT, a Zurich based start-up company. Overall, the project results will have important economies for society at large, including patients and hospitals as a result of better and safer diagnostics and lower costs.